Bishal Gyawali, Professor at Queen’s University, shared a post on LinkedIn:
“Probably one of my most important papers. Let’s hope this drives change. Presentations and papers claiming ‘toxicities were acceptable’ is no longer acceptable. Great to see accompanying powerful piece from patient’s perspective as well.”
Title: Downplaying toxicities in cancer drug trials is not acceptable
Authors: Bishal Gyawali
Read the Full Article.
Other articles featuring Bishal Gyawali on OncoDaily.
